-

M&B Sciences Inc Acquires Clara Health and Announces Goal to Become a Leader in Patient Recruitment and Retention in Clinical Trials

SAN DIEGO, Calif.--(BUSINESS WIRE)--M&B Sciences Inc, a fast-growing African-American owned, technology-driven clinical research organization, announces the acquisition of Clara Health, a company dedicated to using technology to increase access to clinical trials. The acquisition was finalized March 1, 2022. The acquisition of the company will expand M&B Sciences’ mission to make clinical trials accessible to all.

With the addition of Clara Health, based in San Francisco, CA, and its innovative patient recruitment and retention technology platform, M&B Sciences has enhanced its ability to bring decentralized and hybrid trial technology tools to its clients while also maintaining its core values of ensuring patient centricity and diversity within clinical trials. Both M&B Sciences and Clara Health were founded on the principle of creating and leveraging technology to bring efficiency in clinical trials and democratize access to clinical trials for ALL communities. The combined company will move forward as M&B Sciences Inc.

“We are excited about the advancement in patient recruitment technology that Clara Health brings with its innovative Clara Platform. We believe this innovation, combined with the significant technological investment that we’ve already made into NeighborhoodTrials.com, positions M&B Sciences to be a leader in the patient recruitment and retention space. Over the next several months we will be working to integrate the Clara Platform with the NeighborhoodTrials platform to combine the best of the patient recruitment and retention services of each, along with the unique spatial epidemiology aspects of NeighborhoodTrials.com. This integration will position M&B as a leader in patient recruitment and retention with a focus on increasing underrepresented populations in clinical trials. The combination of the two companies will allow M&B to provide an even greater depth and breadth of expertise while continuing to support a dynamic, inclusive, and supportive trial experience for patients and providers,” said Dr. Eddilisa Martin, CEO of M&B Sciences Inc.

“This acquisition is an important milestone for both companies,” said M&B’s Executive Vice President and Chief Strategy Officer, Scott Schliebner, an industry expert on patient-focused drug development and rare disease clinical trials. “With the addition of Clara Health’s technology platform integrated with M&B’s neighborhoodtrials.com patient recruiting platform, we will be able to not only better serve existing clients but also expand their reach and support new customers. Moreover, having Clara Health’s experienced team and their expertise will allow us to successfully scale and accelerate the solutions we provide for our biotech and pharma customers.”

Clara Health’s Co-founders, Evan Ehrenberg and Sol Chen, founded Clara Health in 2015 and have served more than thirty (30) biotech and pharmaceutical clients and contributed to the success of their clinical trials through implementation of innovative patient centric technology tools.

Financial terms of the transaction were not disclosed.

About M&B Sciences Inc

Based in San Diego California, M&B Sciences Inc is a technology driven contract research organization that provides patient recruitment, patient engagement, trial operations, project management, data analytics, and post surveillance marketing research to its biotechnology, pharmaceutical and healthcare customers; for more information, visit www.mbsciences.com.

About Clara Health

Today, clinical trials are the longest and most expensive step in bringing a new treatment to market, and over 80% of trials run are delayed due to difficulty finding participants. Clara Health was created in 2015 from a collaboration with patient advocates to make it simple and approachable to find and connect to clinical trials that fit them best. The platform has since expanded to support protocol design, site selection, and retention as well.

In democratizing access to clinical trials for all patients from all socioeconomic backgrounds Clara Health aimed to make healthcare more diverse, open, and welcoming.

Contacts

M&B Sciences Inc Contacts:

Eddilisa Martin, PharmD, Cofounder & CEO
eddilisa.martin@mbsciences.com
Ph: 858-812-8735

Scott Schliebner, MPH, Executive Vice President, and Chief Strategy Officer
scott.schliebner@mbsciences.com
Ph: 858-812-8735

M&B Sciences Inc

Details
Headquarters: San Diego, California
CEO: Eddilisa Martin
Employees: 20
Organization: PRI

Release Summary
M&B Sciences Inc Acquires Clara Health and Announces Goal to Become a Leader in Patient Recruitment and Retention in Clinical Trials
Release Versions

Contacts

M&B Sciences Inc Contacts:

Eddilisa Martin, PharmD, Cofounder & CEO
eddilisa.martin@mbsciences.com
Ph: 858-812-8735

Scott Schliebner, MPH, Executive Vice President, and Chief Strategy Officer
scott.schliebner@mbsciences.com
Ph: 858-812-8735

Social Media Profiles
More News From M&B Sciences Inc

M&B Sciences Releases Neighborhood Trials App To Improve Diversity In Clinical Trials

SAN FRANCISCO--(BUSINESS WIRE)--M&B Sciences is proud to introduce the NeighborhoodTrials mobile app, which will make it easier for patients from diverse backgrounds to find clinical trials close to home. The app, available in the Apple App Store and in Google Play, allows users to search for clinical trials for conditions they may have or trials happening in their area. Users have the option to receive notifications, request more information, or apply to participate directly through the se...

Clara Health, Now a Part of M&B Sciences, Named Among California’s Most Innovative Clinical Trial Companies

SAN FRANCISCO--(BUSINESS WIRE)--Clara Health, now M&B Sciences, has been named among the top 35 most innovative clinical trial companies in the Bay Area by Best Startup California. The directory tracks more than 300,000 companies in California and selected the finalists for their track record, executive leadership team, market share, innovation, and environment, social and governance (ESG) rating. Clara Health has been a leader in patient recruitment and retention technology since 2015 and...

Scott Schliebner to join 2M Clinical Inc. as Executive Vice President and Chief Strategy Officer

ARLINGTON, Texas--(BUSINESS WIRE)--2M Clinical Inc., creator of NeighborhoodTrials.com, brings former PRA rare disease executive, Scott Schliebner, on board....
Back to Newsroom